Clinical trials: Dysglobulinemia
Dysglobulinemia
Familial Dysglobulinemia
Multiple Myeloma (MM) is a malignant proliferation of monoclonal plasma cells. Myeloma accounts for almost 14% of all hematologic cancers and is essentially incurable.
- Trial name
- PreFamDys (NCT02853214)
- Testing
- Genetic analysis of peripheral blood samples
- Where
- 47 sites in France
- Volunteers
- 1,868 people, healthy volunteers welcome
- Sponsor
- Hospices Civils de Lyon